LONDON-A new study shows that HIV patients are often diagnosed years after their infection, taking away valuable treatment time.
In the United Kingdom, more than one third of HIV patients were diagnosed having a CD4+ cell count of less than 200 cells/µl. This late of a diagnosis puts the patient at an increased risk of infection and limits the chance of successful antiretroviral therapy.
Researchers from the Royal Sussex County Hospital and the Sussex Beacon looked at whether healthcare workers were missing HIV infections when examining patients. After looking at the treatment histories of 49 patients with newly diagnosed HIV from 1997 to 2000, they found 25 patients had been to hospital clinics before being diagnosed. There were five patients who had actually been admitted and treated prior to their diagnosis. Within this group, the average time between the first hospital visit and HIV diagnosis was 995 days. Their mean CD4+ cell count at diagnosis was 76 cells/µl. There were 17 HIV-related deaths in this group between 1997 and 2000, 13 of those patients being in the late diagnosis group.
With these findings, the researchers announced there is an increased need to educate non-HIV specialists about HIV infection. Hospitals and other healthcare organizations should give healthcare workers more information about the virus and how they should test for the disease.
Information from www.hivandhepatitis.com
Show, Tell, Teach: Elevating EVS Training Through Cognitive Science and Performance Coaching
April 25th 2025Training EVS workers for hygiene excellence demands more than manuals—it requires active engagement, motor skills coaching, and teach-back techniques to reduce HAIs and improve patient outcomes.
The Rise of Disposable Products in Health Care Cleaning and Linens
April 25th 2025Health care-associated infections are driving a shift toward disposable microfiber cloths, mop pads, and curtains—offering infection prevention, regulatory compliance, and operational efficiency in one-time-use solutions.
Phage Therapy’s Future: Tackling Antimicrobial Resistance With Precision Viruses
April 24th 2025Bacteriophage therapy presents a promising alternative to antibiotics, especially as antimicrobial resistance continues to increase. Dr. Ran Nir-Paz discusses its potential, challenges, and future applications in this technology.
Robust infectious disease surveillance, including rapid subtyping of influenza A, is essential for early detection, containment, and public health reporting of novel viral threats.